Kedrion IVIG 10%

intravenous immunoglobulin G · Kedrion S.p.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kedrion IVIG 10%, covering 2021-02-16 to 2021-02-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID) [Phase 3]